In this article, we will take a look at the 14 Best Small Cap Stocks to Buy Right Now.
The S&P 600 and S&P BSE Small Cap indexes had soared 0.29% and 0.30%, respectively, while the Russell 2000 has jumped nearly 0.48% as of September 8. The U.S. job growth weakened acutely during August 2025, and the unemployment rate soared to almost a four-year high of 4.3%.
READ ALSO: 11 Low Price High Volume Stocks to Buy According to Analysts and 10 Best AI Software Stocks to Buy Now.
The U.S. labor data shows that labor market conditions are softening and moving towards a Fed interest rate cut later this month. The global head of FX research at HSBC, Paul Mackel, pointed out that “the data raises the question as to whether U.S. employment conditions are now shifting from cooling to deteriorating and if the Fed should cut rates faster.”
Mackel said that this has opened the door for the USD to weaken again, but the recent political tension around the yen and euro increases the likelihood of dollar weakness being reflected more easily against other currencies.
On September 7, the Treasury Secretary Scott Bessent said that he is confident that the President’s tariff plan will win at the Supreme Court. However, Bessent warned his agency would be forced to issue massive refunds in case the court gives a ruling against the tariffs.
“We would have to give a refund on about half the tariffs, which would be terrible for the Treasury,” Bessent said during an interview on NBC’s “Meet the Press.”
On August 14, BTIG analyst Jonathan Krinsky appeared on CNBC for an interview and talked about the sustainability of the recent small-cap rally. Krinsky mentioned that the current market situation resembles July 2024, when small caps were mostly flat while the Nasdaq performed well. The analyst added that following a better-than-expected CPI report, the small caps surged. This becomes more relevant as the markets are priced in for a September rate cut, Krinsky added.
Krinsky’s comments on the small caps seem to follow the similar trajectory, with the market indicating positive signals upon potential Fed interest rates.
With these market trends in mind, let’s turn to the 14 Best Small Cap Stocks to Buy Right Now.
Our Methodology
To compile the list of 14 best small cap stocks to buy right now, we shortlisted companies with a market capitalization equal to or under $2 billion from the Finviz screener. We then ranked these stocks in ascending order of the number of hedge fund holders. The data for hedge funds is taken from Insider Monkey’s Hedge Fund database, updated as of Q2 2025.
Note: The data was recorded on September 5.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
14 Best Small Cap Stocks to Buy Right Now
14. JetBlue Airways Corporation (NASDAQ:JBLU)
Market Capitalization: $1.84 Billion
Number of Hedge Fund Holders: 25
JetBlue Airways Corporation (NASDAQ:JBLU) is one of the best small cap stocks to buy right now. On September 4, JetBlue Airways Corporation (NASDAQ:JBLU) announced that it became the first airline to sign on with Amazon’s Project Kuiper.
JetBlue’s collaboration with Amazon makes it the first airline corporation to join Project Kuiper. This brings faster and more reliable connectivity to JetBlue’s popular onboard Wi-Fi, Fly-Fi. The airline company launched Fly-Fi in 2013 to become the first and still only leading U.S. airline to provide free, high-speed Wi-Fi on every aircraft of its fleet.
“Our agreement with Project Kuiper marks an exciting leap forward for us as the hands-down leader in onboard connectivity. Whether it’s binge-watching a favorite show, staying connected with loved ones, or wrapping up a work project, we’re always looking for ways to make our customers’ time in the air as connected and productive as they want it to be,” said Marty St. George, president, JetBlue.
Project Kuiper’s advanced cutting-edge technology will be available on JetBlue’s aircraft in 2027, marking the next evolution of Fly-Fi and in-flight connectivity. This move is part of JetBlue’s JetForward strategy, which focuses on providing services that customers value most.
JetBlue Airways Corporation (NASDAQ:JBLU) provides air transportation services across North America, South America, and Europe. The company’s fleet consists of five types of aircraft, including Airbus A220, Airbus A320, Airbus A321, Airbus A321neo, and Embraer E190.
13. ICF International, Inc. (NYSE:ICFI)
Market Capitalization: $1.75 Billion
Number of Hedge Fund Holders: 26
ICF International, Inc. (NYSE:ICFI) is one of the best small cap stocks to buy right now. On August 25, ICF International, Inc. (NYSE:ICFI) received a new, multi-year contract worth $40 million to implement large-scale residential energy programs.
ICF International will implement large-scale residential energy programs across six Southern California counties. In collaboration with local community organizations, ICF will help the counties integrate high-impact, no-cost energy and electrification upgrades. This upgrade will help thousands of households improve indoor air quality and reduce energy bills.
“Communities across the country are experiencing a tension between reliable power and affordability. We’re proud to couple three decades of energy program experience with the latest technology to help Southern California households have more reliable and affordable energy,” said Anne Choate, ICF executive vice president for energy, environment, and infrastructure.
ICF International will also install advanced digital twin technology to simulate, monitor, and analyze grid impact in a virtual environment before deployment. A few weeks prior to the company’s recent contract announcement, on August 11, Barrington increased its price target on ICFI from $102 to $107, keeping its Outperform rating on the stock. Kevin Steinke from Barrington remains optimistic on ICF International as the company continues to gain revenue from commercial energy clients, driven by robust demand for energy efficiency programs.
As of September 5, ICF International, Inc.’s (NYSE:ICFI) average price target of $98.50, based on analysts’ estimates, implies an upside of approximately 3.46% from current levels.
ICF International, Inc. (NYSE:ICFI) provides management, technology, and policy consulting and implementation services to government and commercial clients.
12. Strategic Education, Inc. (NASDAQ:STRA)
Market Capitalization: $1.96 Billion
Number of Hedge Fund Holders: 26
Strategic Education, Inc. (NASDAQ:STRA) is one of the best small cap stocks to buy right now. On September 4, Truist Financial reiterated its Buy rating on Strategic Education, Inc. (NASDAQ:STRA), without giving a price target to the stock.
Jasper Bibb is observing the firm before setting a price target as Truist is set to meet with the management and explore the company’s future strategies scheduled on September 9.
Bibb remains cautious due to Strategic Education’s Q2 FY2025 student enrollment within USHE declining by 0.8% to 86,339 compared to 87,077 from a year ago. Whereas, the student enrollment within ANZ dropped 3.1% to 18,524 compared to 19,113 year-over-year. However, the company is experiencing strong growth at Sophia Learning, where the average total subscribers increased nearly 40% from a year ago, while Sophia Learning revenue soared 39.8% to $16.4 million. These mixed results led to a revenue of $321.5 million, up 2.9% from a year ago and slightly missing consensus. The adjusted earnings per share of $1.52 were ahead of the estimates of $1.43.
As of September 5, Strategic Education, Inc.’s (NASDAQ:STRA) average price target of $105, based on analysts’ estimates, implies an upside of nearly 28.11% from current levels.
Strategic Education, Inc. (NASDAQ:STRA) offers education services via campus-based and online post-secondary education, and programs to develop job-ready skills. The company operates through three segments, including the U.S. Higher Education (USHE), Australia/New Zealand (ANZ), and Education Technology Services.
11. Arlo Technologies Inc. (NYSE:ARLO)
Market Capitalization: $1.89 Billion
Number of Hedge Fund Holders: 27
Arlo Technologies Inc. (NYSE:ARLO) is one of the best small cap stocks to buy right now. On August 26, Lake Street reiterated the Buy rating on Arlo Technologies Inc. (NYSE:ARLO) stock, keeping the price target at $24.
Jacob Stephan from Lake Street remains optimistic about Arlo Technologies as the company has announced an all-new lineup of smart home security solutions with advanced AI-powered systems. On August 26, Arlo introduced new models across the entire range from Essential to Pro and Ultra Series. The company’s new lineup provides users with more ways to protect their homes. The informative, actionable alerts, and easy-to-install DIY indoor and outdoor security cameras offer high-level security features to users. The two all-new pan-tilt models come with 360-degree coverage for ultimate security offerings.
“Building on the successful launch of Arlo Secure 6 and its advanced AI capabilities earlier this year, we’re excited to introduce our all-new lineup that leverages all of the advanced capabilities of Arlo Intelligence to deliver smarter, safer, and more comprehensive smart home security,” said Matthew McRae, CEO of Arlo Technologies.
Stephan continues to weigh on ARLO, a company with over 5 million subscribers globally. The analyst sees this all-new product lineup as a crucial mover for the company, providing security services that continue to lead the market.
As of September 5, Arlo Technologies Inc.’s (NYSE:ARLO) average price target of $22, based on analysts’ estimates, implies an upside of nearly 21.35% from current levels.
Arlo Technologies Inc. (NYSE:ARLO), together with its subsidiaries, offers cloud-based platform services. The company offers advanced home, business, and personal security services through Arlo Essential Cameras and Doorbells.
10. V2X, Inc. (NYSE:VVX)
Market Capitalization: $1.78 Billion
Number of Hedge Fund Holders: 27
V2X, Inc. (NYSE:VVX) is one of the best small cap stocks to buy right now. On August 27, Noble Financial reiterated its Buy rating on V2X, Inc. (NYSE:VVX), keeping the price target at $72.
Joe Gomes from Noble Financial reaffirmed the rating on VVX as the analyst sees momentum in the company following an acquisition announcement on August 12. V2X signed an agreement to acquire a specialized data engineering, intel mission support, and cyber solutions business serving the Intelligence Community. This will allow V2X to have access to new channels, capabilities, and further enhance its position within the national security space. This will also expand V2X’s solutions to support mission-critical operations in the cyber domain.
Gomes’ positive stance on VVX also indicates the company’s strong performance during Q2 FY2025, posting revenue of $1.08 billion, exceeding consensus by $19.72 million. The adjusted EPS saw a notable increase of 59% from a year ago to $1.33, and surpassed estimates by $0.29 per share. The company maintains its revenue guidance for FY2025 between $4.375 billion and $4.50 billion, while it has upgraded the adjusted EPS range to $4.65 to $4.95 from the previous guidance of $4.45 to $4.85. On top of this, Gomes’ bullish sentiment is justified by another positive development, with the company receiving a $4.3 billion indefinite delivery/quantity contract by the U.S. Air Force for services in support of the T-6 aircraft.
V2X, Inc. (NYSE:VVX) offers critical mission solutions and provides support services to defense customers globally. The company offers various integrated solutions across the aerospace, training, technology, operations, and logistics markets.
9. Pheresis, Inc. (NASDAQ:PHR)
Market Capitalization: $1.68 Billion
Number of Hedge Fund Holders: 28
Pheresis, Inc. (NASDAQ:PHR) is one of the best small cap stocks to buy right now. On September 5, Truist Financial raised the price target on Pheresis, Inc. (NASDAQ:PHR) from $35 to $36, keeping its Buy rating on the stock.
Jailendra Singh from Truist increased the price target on PHR following a post-quarter call with management to discuss its Q2 FY2026 results, full-year expectations, and acquisition of AccessOne. Singh noted that the company’s Q2 results were in line with expectations, with a total revenue of $117.3 million, up 15% from a year ago. The adjusted EBITDA was around $22 million, ahead of consensus and a notable increase of $16 million year-over-year.
Singh remains positive about Pheresis, Inc. (NASDAQ:PHR) as the company updated its FY2026 adjusted EBITDA outlook to around $87 million to $92 million, a $2 million increase at both ends of the last range. The company retained the revenue outlook at $472 million to $482 million. Moreover, Pheresis has signed a definitive agreement to acquire Access One for $160 million. Access One is a market leader in providing financing solutions for healthcare receivables, working with some of the largest health systems in the U.S. The analyst mentioned that this major development could boost the company’s addressable market by almost $6 billion.
Pheresis, Inc. (NASDAQ:PHR) provides comprehensive software solutions that enhance the operational and financial performance of healthcare organizations. The company’s solutions include SaaS-based integrated tools that manage patient access, registration, and payments.
8. Seadrill Limited (NYSE:SDRL)
Market Capitalization: $1.98 Billion
Number of Hedge Fund Holders: 28
Seadrill Limited (NYSE:SDRL) is one of the best small cap stocks to buy right now. On August 28, Citi upgraded the price target on Seadrill Limited (NYSE:SDRL) from $36 to $40, maintaining its Buy rating on the stock.
Scott Gruber from Citi raised the price target on SDRL, citing the increase to Seadrill’s FY2026 estimates. Wall Street expects Seadrill’s FY2026 revenue to be around $1.37 billion, while earnings per share are projected at $1.14, compared to the FY2025 projection of $0.22 per share. On August 6, the company posted Q2 FY2025 results, posting $377 million in total revenue, exceeding the top end of the consensus and increasing $42 million from last quarter.
The company’s West Vela continued robust operating performance, and the Sevan Louisiana contract award expanded its customer base. In line with these developments, on August 25, Seadrill’s joint venture with an affiliate of Sonangol, Sonadrill Holding Ltd., received two contracts. These contracts position the joint venture for long-term success.
As of September 5, Seadrill Limited’s (NYSE:SDRL) average price target of $34, based on analysts’ estimates, implies an upside of nearly 3.79% from current levels.
Seadrill Limited (NYSE:SDRL) offers offshore drilling services to the oil and gas industry worldwide.
7. Centuri Holdings Inc. (NYSE:CTRI)
Market Capitalization: $1.91 Billion
Number of Hedge Fund Holders: 30
Centuri Holdings Inc. (NYSE:CTRI) is one of the best small cap stocks to buy right now. On August 27, Centuri Holdings Inc. (NYSE:CTRI) announced customer awards worth over $300 million.
These awards complement the previously announced $550 million in customer awards on July 9. These awards indicate the robust demand for Centuri’s comprehensive mix of energy solutions among utility and infrastructure clients across the United States.
“We’re pleased with the continued strong momentum in our bidding and commercial successes into the second half of the year. Our most recent awards are the result of our deliberate strategy to capture end-market opportunities and deliver profitable growth. Customers continue to respond well to the positioning of our differentiated offering, which provides the assets, capabilities, and people resources our customers need to deliver reliable power—all under one umbrella,” said Centuri President and CEO Christian Brown.
The announced awards’ revenue value includes additional scopes of work to support data center units across Pennsylvania, an MSA renewal with a long-standing utility customer in the Northeast, and two new contracts to perform distribution work for gas and electric utilities in the Midwest and Southeast. The awarded scopes include operations to support utility capital plans; electric transmission line relocation and grid hardening, and upgrading and replacing aging infrastructure.
Centuri Holdings Inc. (NYSE:CTRI) is a utility infrastructure services firm that offers utilities to build and maintain the energy network that powers millions of homes in the U.S. and Canada.
6. Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Market Capitalization: $2 Billion
Number of Hedge Fund Holders: 32
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) is one of the best small cap stocks to buy right now. On September 3, Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) submitted a supplemental New Drug Application to the U.S. FDA to expand the indication of ZORYVE.
Arcutis Biotherapeutics’ application for ZORYVE cream 0.3% is developed for the treatment of plaque psoriasis in children down to the age of two. Arcutis’ cream is uniquely formulated to be effective, safe, and well-tolerated for all areas of the body. ZORYVE can be used on sensitive areas such as intertriginous skin, where plaque psoriasis often presents in children.
“Today, there are very limited FDA-approved treatment options for plaque psoriasis for children under 6, who often present with disease on sensitive skin such as the face and intertriginous areas. There is a significant unmet need for non-steroidal options that can effectively treat plaque psoriasis over the long term. If approved, investigational ZORYVE cream could be an important first-line treatment option for children as young as age two,” said Adelaide Hebert, MD, professor and chief of pediatric dermatology at UTHealth Houston.
If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor. It would become an alternative to topical steroids and vitamin-D analogs, offering an important alternative for patients. So far, the results from the long-term study indicate consistent favorable safety and tolerability along with efficacy across the age ranges studied.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) is a biopharmaceutical company that is engaged in developing and commercializing treatments for dermatological diseases.
5. QuidelOrtho Corporation (NASDAQ:QDEL)
Market Capitalization: $1.94 Billion
Number of Hedge Fund Holders: 31
QuidelOrtho Corporation (NASDAQ:QDEL) is one of the best small cap stocks to buy right now. On September 2, RBC Capital raised the price target on QuidelOrtho Corporation (NASDAQ:QDEL) stock from $60 to $62, keeping its Buy rating.
Conor McNamara from RBC Capital increased the price target on QDEL followed by QuidelOrtho’s completion of a series of transactions to refinance its debt structure and support future growth. On August 22, the company announced that it had extended its debt maturities and reduced required amortization payments.
“We are pleased to successfully complete our debt refinancing, which allows us to strengthen our capital structure while maintaining financial flexibility. Our highest capital allocation priority remains reducing our total debt and net debt leverage. By improving the debt covenant terms and reducing the required amortization over the life of the loan, we will have greater financial flexibility and options to fund the continued growth of our business, while also improving our cash flow,” said Joseph Busky, Chief Financial Officer, QuidelOrtho.
McNamara remains positive on QuidelOrtho as the company experienced notable growth in international markets during Q2 FY2025, particularly across Latin America, Japan, Asia Pacific, and EMEA regions. Moreover, the company is focused on its molecular strategy, especially the acquisition of LEX Diagnostics, which is expected to improve its growth potential.
As of September 5, QuidelOrtho Corporation’s (NASDAQ:QDEL) average price target of $37.50, based on analysts’ estimates, implies an upside of almost 30.75% from current levels.
QuidelOrtho Corporation (NASDAQ:QDEL) offers diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.
4. Voyager Technologies Inc. (NASDAQ:VOYG)
Market Capitalization: $1.73 Billion
Number of Hedge Fund Holders: 34
Voyager Technologies Inc. (NASDAQ:VOYG) is one of the best small cap stocks to buy right now. On September 2, Barclays reiterated the Hold rating on Voyager Technologies Inc. (NASDAQ:VOYG), keeping the price target at $45.
David E. Strauss from Barclays reaffirmed the rating on VOYG as the analyst sees the company’s strong positioning in missile and missile defense programs. Strauss believes that this will drive rapid growth and improved profitability for Voyager Technologies. The analyst cited that the company’s large pipeline of opportunities in the defense sector makes it a compelling investment among small cap defense and space industry players.
Voyager Technologies is also investing in a leading AI software company, Latent AI. On August 18, the company announced that it is investing in Latent AI, which will help Voyager accelerate development of its AI. The AI firm will assist Voyager to broaden its hardware reach and put AI-ready processors in Voyager-built craft.
“We’re making the leap from merely collecting data at the edge to understanding it instantly, putting mission intelligence where the mission happens in real time,” said Dylan Taylor, CEO, Voyager Technologies.
Barclays continues to see potential upside in VOYG, considering these growth prospects and investment opportunities. As of September 5, Voyager Technologies Inc.’s (NASDAQ:VOYG) average price target of $50, based on analysts’ estimates, implies an upside of nearly 69.95% from current levels.
Voyager Technologies Inc. (NASDAQ:VOYG) is a defense technology and space solutions company. It operates through three segments, including Defense & National Security, Space Solutions, and Starlab Space Stations.
3. LegalZoom.com Inc. (NASDAQ:LZ)
Market Capitalization: $1.86 Billion
Number of Hedge Fund Holders: 35
LegalZoom.com Inc. (NASDAQ:LZ) is one of the best small cap stocks to buy right now. On August 25, Citi upgraded the price target on LegalZoom.com Inc. (NASDAQ:LZ) from $10 to $12, keeping its Neutral rating on the stock.
Citi analyst Ronald Josey raised the price target post the second quarter FY2025 earnings, which reflected robust subscription revenue. LegalZoom posted $192.5 million in revenue, exceeding the estimated $182.70 million and growing 9% year-over-year. Josey sees LegalZoom’s subscription strategy to be working well for the company, with improvements in product packaging, pricing, and personalization leading to higher engagement, especially in compliance-related services. LegalZoom’s management also attributed the robust quarterly performance to strong adoption of new compliance-focused offerings and improvement to the firm’s bundled subscription tiers.
In line with its strong performance and strategic developments during Q2, LegalZoom.com Inc. (NASDAQ:LZ) announced the expansion of its intellectual property legal services to include patent filings through LegalZoom’s law firm, LZ Legal Services, on August 19. The company’s law firm will offer affordable patent protection via intelligent technology and licensed patent attorneys at low costs compared to traditional fees.
The demand for IP protection is at an all-time high. Considering the need for accessible and cost-effective patent solutions, LegalZoom is reconceptualizing the provisional patent application filing experience. This new idea is to make the application filing faster, simpler, and more affordable than before.
As of September 5, LegalZoom.com Inc.’s (NASDAQ:LZ) average price target of $12, based on analysts’ estimates, implies an upside of nearly 16.28% from current levels.
LegalZoom.com Inc. (NASDAQ:LZ), through its subsidiaries, operates an online platform that supports the legal, compliance, and business management needs of SMEs and consumers in the U.S.
2. Dyne Therapeutics, Inc. (NASDAQ:DYN)
Market Capitalization: $2 Billion
Number of Hedge Fund Holders: 43
Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the best small cap stocks to buy right now. On August 25, Raymond James increased the price target on Dyne Therapeutics, Inc. (NASDAQ:DYN) stock from $31 to $35, maintaining its Buy rating.
Martin Auster from Raymond James upgraded the price target on DYN as he remains optimistic on the upcoming DYNE-251 registrational cohort readout expected in late 2025. Auster sees potential in the upcoming investigational exon-skipping therapy for Duchenne Muscular Dystrophy (DMD). The company expects a Biologics License Application (BLA) filing in early 2026. The analyst’s confidence is based on three major factors, including the differentiated profile of DYNE-251 compared to Exondys 51, a competing therapy in the DMD treatment space.
On August 4, Dyne Therapeutics announced the FDA approval for the treatment of patients with DMD. Auster believes in a pathway to accelerated approval for the therapy, which could boost its market entry if successful in clinical trials.
“This Breakthrough Therapy Designation for DYNE-251 is a testament to its potential as a next-generation therapy designed to bring meaningful functional improvement to individuals with DMD for whom exon 51 skipping can lead to the production of near full-length dystrophin,” said Doug Kerr, M.D., Ph.D., chief medical officer of Dyne Therapeutics.
As of September 5, Dyne Therapeutics, Inc.’s (NASDAQ:DYN) average price target of $38, based on analysts’ estimates, implies an upside of nearly 167.23% from current levels.
Dyne Therapeutics, Inc. (NASDAQ:DYN) is a clinical-stage neuromuscular disease company that focuses on discovering and developing therapeutics for neuromuscular diseases.
1. Victoria’s Secret & Co. (NYSE:VSCO)
Market Capitalization: $1.99 Billion
Number of Hedge Fund Holders: 44
Victoria’s Secret & Co. (NYSE:VSCO) is one of the best small cap stocks to buy right now. On August 29, UBS raised the price target on Victoria’s Secret & Co. (NYSE:VSCO) from $21 to $25, keeping its Neutral rating on the stock.
Mauricio Serna from UBS increased the price target on VSCO following the Q2 FY2025 earnings release. The analyst pointed out that the company’s quarterly report shows its turnaround is gaining traction. Victoria’s Secret surpassed its top and bottom line guidance and also exceeded analyst consensus by $52.92 million, posting $1.46 billion in revenue during Q2. The company’s net sales soared 3% year-over-year, with comp sales growing by 4%, reflecting robust momentum across both Victoria’s Secret and PINK brands.
International sales were the key to strong performance for the company, growing 22% year-over-year, indicating the strength of global partnerships and brand relevance. The launch of the Body by Victoria Collection was a success, bringing in double-digit new customer growth and increased engagement. On August 28, Barclays analyst Adrienne Yih also increased the price target on VSCO from $23 to $27, keeping its Buy rating. The analyst remains positive on Victoria’s Secret’s strong growth in Q2 and its raised FY2025 outlook, with net sales expected between $6.33 billion and $6.41 billion compared to the previous guidance of $6.20 billion and $6.30 billion.
As of September 5, Victoria’s Secret & Co. (NYSE:VSCO) average price target of $23, based on analysts’ estimates, implies a downside of almost 12.38% from current levels.
Victoria’s Secret & Co. (NYSE:VSCO) is a leading specialty retailer for women’s intimate apparel and other apparel and beauty products. The company sells its products under the Victoria’s Secret, PINK, and Adore Me brands.
While we acknowledge the potential of VSCO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than VSCO and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
